Calamos Advisors
MACK

Calamos Advisors’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Calamos Advisors’s Portfolio MACK Stock Details MACK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-7,359
Closed -$220K – 642
2013
Q3 		$220K Buy
+7,359
New +$220K ﹤0.01% 570